Ads
related to: diabetic nephropathy diagnosis and treatment- Dosing & Administration
Learn How This Treatment Is
Administered And The Dosing Regimen
- Efficacy Data
Read The Data About The Efficacy Of
This IgAN Treatment Option.
- Mechanism Of Action
See How This Treatment Option Works
And Download Resources Today.
- Start Form
Visit The HCP Site Today To
Download The Start Form.
- Important Safety Info
See Important Safety Information
About This IgAN Treatment Option.
- HCP Resources
Visit Today To Download Various
Resources For Your IgAN Practice.
- Dosing & Administration
Search results
Results From The WOW.Com Content Network
Diabetic nephropathy is the most common cause of end-stage renal disease and is a serious complication that affects approximately one quarter of adults with diabetes in the United States. [ 13 ] [ 14 ] Affected individuals with end-stage kidney disease often require hemodialysis and eventually kidney transplantation to replace the failed kidney ...
Diabetic nephropathy is a progressive kidney disease caused by angiopathy of the capillaries in the glomeruli. It is characterized by nephrotic syndrome and diffuse scarring of the glomeruli . It is particularly associated with poorly managed diabetes mellitus and is a primary reason for dialysis in many developed countries.
Persons with nephrogenic diabetes insipidus must consume enough fluids to equal the amount of urine produced. Any underlying cause such as high blood calcium must be corrected to treat nephrogenic diabetes insipidus. The first line of treatment is hydrochlorothiazide and amiloride. [10] Patients may also consider a low-salt and low-protein diet.
Most young Type 1 diabetic patients experience glomerular hyperfiltration, a typical functional deviation in insulin-dependent diabetes mellitus. [4] A meta-analysis of research done on Type 1 diabetic subjects found that people with glomerular hyperfiltration have a higher chance of developing albuminuria and seeing their diabetic nephropathy worsen. [5]
This is an accepted version of this page This is the latest accepted revision, reviewed on 15 January 2025. Group of endocrine diseases characterized by high blood sugar levels This article is about the common insulin disorder. For the urine hyper-production disorder, see Diabetes insipidus. For other uses, see Diabetes (disambiguation). Medical condition Diabetes Universal blue circle symbol ...
Denial of care in chronic kidney disease treatment and management is a significant issue for minority populations. This can be due to healthcare provider bias, structural barriers, and health insurance coverage disparities. Healthcare provider biases can lead to under-treatment, misdiagnosis, or delayed diagnosis.
Ad
related to: diabetic nephropathy diagnosis and treatment